GENNEX LABORATORIES
Back to Balance Sheet
|
GENNEX LABORATORIES Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹40 Cr | ₹30 Cr | ₹24 Cr | ₹19 Cr | ₹21 Cr |
What is the latest Total Current Liabilities ratio of GENNEX LABORATORIES ?
Year | Total Current Liabilities |
---|---|
Mar2024 | ₹40 Cr |
Mar2023 | ₹30 Cr |
Mar2022 | ₹24 Cr |
Mar2021 | ₹19 Cr |
Mar2020 | ₹21 Cr |
How is Total Current Liabilities of GENNEX LABORATORIES Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹40 Cr | 36.57 | |
Mar2023 | ₹30 Cr | 21.91 | |
Mar2022 | ₹24 Cr | 27.25 | |
Mar2021 | ₹19 Cr | -8.79 | |
Mar2020 | ₹21 Cr | - |
Compare Total Current Liabilities of peers of GENNEX LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GENNEX LABORATORIES | ₹320.6 Cr | -1.9% | 8.3% | -4.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹405,991.0 Cr | -0.1% | 1.3% | 5% | Stock Analytics | |
DIVIS LABORATORIES | ₹175,720.0 Cr | -1.7% | 0.5% | 47.2% | Stock Analytics | |
CIPLA | ₹120,133.0 Cr | 0.4% | -1.5% | -1.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹118,994.0 Cr | -0.2% | 9% | 13.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,562.0 Cr | 0.5% | -5.7% | -9.1% | Stock Analytics |
GENNEX LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GENNEX LABORATORIES | -1.9% |
8.3% |
-4.8% |
SENSEX | -0.1% |
0.2% |
2.1% |
You may also like the below Video Courses